Patient safety in medical research is paramount, as it directly affects the ethics and efficacy of clinical trials designed to enhance healthcare outcomes.The recent halt in funding has created a significant disruption in medical research oversight, threatening the essential framework provided by Institutional Review Boards (IRBs) to safeguard patients’ rights in studies.